Inventurus Knowledge Solutions Reports Robust Q1 FY26 Results with 59% Surge in Net Profit
Inventurus Knowledge Solutions (NSE: IKS) announced robust Q1 FY26 financial results. Net profit surged 59% year-on-year to 1.52 billion rupees, while revenue grew 16% to 7.4 billion rupees. EBITDA margin improved to 32.1% from 27.3% in Q1 FY25. The company reported new partnerships and expansions, including collaborations with Mission Community Hospital and Bicycle Health. Key management changes include Sachin K. Gupta's designation as Global CEO of the US subsidiary, Nithya Balasubramanian's appointment as Additional Director, and Dr. Garheng Albert Kong joining as an Independent Director.

*this image is generated using AI for illustrative purposes only.
Inventurus Knowledge Solutions Limited (NSE: IKS) has reported strong financial results for the first quarter of fiscal year 2026, showcasing significant growth in both revenue and profitability.
Financial Highlights
The technology-enabled healthcare solutions provider announced a consolidated net profit of 1.52 billion rupees for Q1 FY26, marking a substantial 59% year-on-year increase from 955 million rupees in the same period last year. This impressive growth in profitability underscores the company's operational efficiency and strong market position.
Revenue for the quarter stood at 7.4 billion rupees, up 16% from 6.4 billion rupees in Q1 FY25. This robust top-line growth reflects the company's ability to expand its market share and capitalize on the growing demand for healthcare technology solutions.
Margin Improvement
Inventurus Knowledge Solutions demonstrated notable improvement in its profit margins. The company's EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) margin expanded to 32.1% in Q1 FY26, up from 27.3% in the corresponding quarter of the previous year. This increase in EBITDA margin indicates enhanced operational efficiency and cost management.
Key Performance Metrics
Metric | Q1 FY26 | Q1 FY25 | YoY Change |
---|---|---|---|
Revenue | 7,401.00 | 6,401.00 | +16.00% |
EBITDA | 2,378.00 | 1,745.00 | +36.30% |
Net Profit | 1,515.00 | 955.00 | +58.70% |
EBITDA Margin | 32.10% | 27.30% | +4.80% |
EPS (Basic) | 9.07 | 5.75 | +57.70% |
Management Commentary
Sachin K. Gupta, Founder & Global CEO of IKS Health, commented on the results: "Our performance this quarter reflects the continued momentum in our business and the stickiness of our integrated tech-led care enablement platform built on strong client relationships, scalable solutions, and disciplined execution. The sustained revenue growth at 16% and improvement of EBITDA margin for the combined entity to 32% demonstrates the impact of our technology-led care enablement platform and global delivery capabilities."
Nithya Balasubramanian, CFO of IKS Health, added: "We delivered a strong financial performance in Q1 FY26, driven by consistent revenue growth and continued focus on operational efficiency. Our EBITDA margin improvement reflects disciplined cost management, scalability of our platform, and prudent capital allocation."
Business Highlights
The company reported several strategic partnerships and expansions during the quarter:
- New partnership with Mission Community Hospital for end-to-end revenue cycle management across hospital acute care and ambulatory surgery spaces.
- Collaboration with Bicycle Health to manage revenue cycle, enabling rapid growth and scale of their virtual network.
- Expanded partnership with OrthoNY to introduce IKS Virtual Clinical Assistant for administrative tasks and clinical efficiencies.
- Extended partnership with a top 5 U.S. health system for coding services to drive revenue performance and mitigate operational inefficiencies.
Corporate Developments
In addition to the financial results, Inventurus Knowledge Solutions announced several key corporate developments:
- Mr. Sachin Gupta has been designated as Global CEO of Inventurus Knowledge Solutions Inc, USA, a wholly-owned subsidiary of the company.
- Ms. Nithya Balasubramanian, the current CFO, has been appointed as an Additional Director (Whole-time Director) on the Board of the Company for a term of 5 years.
- Dr. Garheng Albert Kong has been appointed as an Additional Director (Non-Executive, Independent) on the Board of the Company for a term of 5 years.
These appointments are subject to shareholder approval and reflect the company's commitment to strengthening its leadership team and corporate governance.
As Inventurus Knowledge Solutions continues to expand its reach and impact in the healthcare technology sector, the strong Q1 FY26 results position the company for sustained growth and value creation in the coming quarters.
Historical Stock Returns for Inventurus Knowledge Solutions
1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
---|---|---|---|---|---|
+0.93% | +0.24% | -1.66% | -6.99% | -18.31% | -18.31% |